Form 4: Natural Alternatives International Inc. Executive Kenneth Wolf Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Kenneth Wolf, President, COO, & Secretary of Natural Alternatives International Inc., reports the resale of shares for tax liability and the grant of restricted stock.

Summary

  • Kenneth Wolf, an officer of Natural Alternatives International Inc. (NAII), filed a Form 4 detailing changes in beneficial ownership.
  • On March 7, 2024, Wolf resold 6,533 shares to the issuer at $5.95 per share to cover tax liabilities from vesting restricted stock.
  • Also on March 8, 2024, Wolf was granted 14,500 shares of restricted stock under the company's 2020 Omnibus Incentive Plan.
  • The restricted stock grant vests in three equal installments on March 7, 2025, March 7, 2026, and March 7, 2027.
  • Following these transactions, Wolf directly owns 139,553 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.

Positives

  • The grant of restricted stock to a key executive aligns their interests with the long-term performance of the company.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates standard compensation practices, including stock-based compensation, common in publicly traded companies.

Comparison to Industry Standards

  • Stock-based compensation is a common practice among publicly traded companies to align the interests of executives with those of shareholders.
  • The vesting schedule of the restricted stock (one-third each year for three years) is a typical vesting arrangement.
  • Comparable companies in the nutritional supplements industry, such as Herbalife Nutrition and USANA Health Sciences, also utilize stock-based compensation as part of their executive compensation packages.

Stakeholder Impact

  • Shareholders may view the stock transactions as part of the executive's compensation package and alignment with company performance.
  • The resale of shares to cover tax liabilities has a minimal impact on the overall market.

Key Dates

DateDescription
03/07/2024Resale of 6,533 shares to the issuer for tax liability at $5.95 per share; vesting of 11,667 shares of restricted stock.
03/08/2024Grant of 14,500 shares of restricted stock.
03/07/2025Vesting of one-third (4,834 shares) of the restricted stock.
03/07/2026Vesting of one-third (4,833 shares) of the restricted stock.
03/07/2027Vesting of the final one-third (4,833 shares) of the restricted stock.
03/11/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.